Differential Distribution and Functional Quality of CMV-Specific T Cell Effector Memory in High-Risk Lung Transplant Recipients

被引：0
|
作者：
Akulian, J. A. [1 ]
Pipeling, M. R. [2 ]
John, E. R. [1 ]
McDyer, J. F. [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Pittsburgh, Sch Med, PACCM, Pittsburgh, PA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 04期
关键词：
D O I：
10.1016/j.healun.2012.01.411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [21] Preservation of CMV-Specific Memory T Cell Responses with Belatacept.
    Xu, H.
    Mehta, A.
    Cheeseman, J.
    Pearson, T.
    Larsen, C.
    Kirk, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 334 - 334
  • [22] CLINICAL VALIDATION OF T-TRACK® CMV TO ASSESS THE FUNCTIONALITY OF CMV-SPECIFIC CELL-MEDIATED IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS
    Banas, B.
    Steubl, D.
    Renders, L.
    Wekerle, T.
    Koch, M.
    Witzke, O.
    Muehlfeld, A.
    Sommerer, C.
    Habicht, A.
    Hugo, C.
    Huenig, T.
    Lindemann, M.
    Barabas, S.
    Deml, L.
    Wagner, R.
    Krueger, B.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 20
  • [23] CMV-specific T-cell Response After Lung Transplantation
    Rossetti, V.
    Morlacchi, L.
    Lunghi, G.
    Briganti, D.
    Renteria, S. Uceda
    Tarsia, P.
    Damarco, F.
    Mendogni, P.
    Palleschi, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S176 - S177
  • [24] Impact of Prolonging CMV Prophylaxis in High-Risk (CMV D plus /R-) Lung Transplant Recipients
    Herrera, S.
    Khan, B.
    Husain, S.
    Binnie, M.
    Chow, C.
    Martinu, T.
    Chaparro, C.
    Keshavjee, S.
    Singer, L. G.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S120 - S120
  • [25] Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir
    Palmer, SM
    Grinnan, DC
    Reams, BD
    Steele, MP
    Messier, RH
    Davis, RD
    CLINICAL TRANSPLANTATION, 2004, 18 (02) : 179 - 185
  • [26] CMV viremia and development of CMV-specific cytotoxic t-cells (CMV-TC) in pediatric renal transplant recipients
    Pizzo, Helen
    Shin, Bongha
    Toyoda, Mieko
    Jordan, Stanley
    Puilyanda, Dechu
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [27] Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D plus /R-): A Case Series
    Andreani, Marine
    Albano, Laetitia
    Benzaken, Sylvia
    Cassuto, Elisabeth
    Jeribi, Ahmed
    Caramella, Anne
    Giordanengo, Valerie
    Bernard, Ghislaine
    Esnault, Vincent
    Seitz-Polski, Barbara
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (01) : 204 - 211
  • [28] CENTRALIZED PRODUCTION AND DISTRIBUTION OF CMV-SPECIFIC CYTOTOXIC T CELL LYMPHOCYTES
    Friedetzky, A.
    Skulte, A.
    Mitra, A.
    Hodgkin, K.
    Peggs, K.
    Newton, K.
    Knaus, R.
    HAEMATOLOGICA, 2013, 98 : 415 - 415
  • [29] Belatacept (CTLA4-Ig) Shows Minimal Suppression of CMV-Specific Memory T Cell (CMV-T) and Antibody (CMV-Ab) in CMV Sero (+) Kidney Transplant Recipients (Tx Pts).
    Ge, S.
    Karasyov, A.
    Petrosyan, A.
    Choi, J.
    Lovato, D.
    Kahwaji, J.
    Lluz, J.
    Vo, A.
    Hayrapetyan, E.
    Jordan, S.
    Toyoda, M.
    TRANSPLANTATION, 2014, 98 : 893 - 893
  • [30] Belatacept (CTLA4-Ig) Shows Minimal Suppression of CMV-Specific Memory T Cell (CMV-T) and Antibody (CMV-Ab) in CMV Sero (+) Kidney Transplant Recipients (Tx Pts)
    Ge, S.
    Karasyov, A.
    Petrosyan, A.
    Choi, J.
    Lovato, D.
    Kahwaji, J.
    Lluz, J.
    Vo, A.
    Hayrapetyan, E.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 893 - 893
12345